NewcelX

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NewcelX and other ETFs, options, and stocks.

About NCEL

NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland. 

CEO
Ronen Twito
CEORonen Twito
Employees
3
Employees3
Headquarters
Kloten, Zurich
HeadquartersKloten, Zurich
Founded
Founded
Employees
3
Employees3

NCEL Key Statistics

Market cap
13.28M
Market cap13.28M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
136.14K
Average volume136.14K
High today
$3.65
High today$3.65
Low today
$2.80
Low today$2.80
Open price
$3.31
Open price$3.31
Volume
113.97K
Volume113.97K
52 Week high
$33.70
52 Week high$33.70
52 Week low
$2.80
52 Week low$2.80

Stock Snapshot

The current NewcelX(NCEL) stock price is $2.80, with a market capitalization of 13.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.

During the trading session on 2025-12-12, NewcelX(NCEL) shares reached a daily high of $3.65 and a low of $2.80. At a current price of $2.80, the stock is 0.0% higher than the low and still -23.3% under the high.

Trading activity shows a volume of 113.97K, compared to an average daily volume of 136.14K.

The stock's 52-week range extends from a low of $2.80 to a high of $33.70.

The stock's 52-week range extends from a low of $2.80 to a high of $33.70.

People also own

Based on the portfolios of people who own NCEL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.